Dianthus Therapeutics Banner

Annual Meeting

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

Dianthus Therapeutics Annual Meeting of Shareholders

May 21, 2026 at 9:00 a.m. ET.

You will be able to attend and participate in the Annual Meeting online by visiting www.proxydocs.com/DNTH, where you will be
able to listen to the meeting live, submit questions and vote.